SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Eisai Company, Ltd. to Submit Marketing Authorization Applications in the U.S. and EU for Perampanel as Adjunctive Therapy for Partial Onset Seizures in Patients with Epilepsy